TRAX — First Tracks Biotherapeutics Share News
0.000.00%
Last trade - 00:00US STOCKS ON THE MOVE-Walmart, Super Micro, FMC
First Tracks Biotherapeutics up after $200 mln equity raise
Health Rounds: New drug treats gluten-caused intestinal damage in celiac patients
US RESEARCH ROUNDUP-Essex Property Trust, Qualys, Vulcan Materials
US STOCKS ON THE MOVE-Microsoft, Salesforce, Bristol Myers
US STOCKS ON THE MOVE-Microsoft, C3.ai, Salesforce, Bristol Myers
US STOCKS ON THE MOVE-Salesforce, Brown & Brown, IonQ, Harmony Biosciences
Corrected: BUZZ-First Tracks surges on positive results from celiac disease drug trial (October 12)
Brief: First Tracks Biotherapeutics Announces Positive Top-Line Results For ANB033 In Gluten-Challenge Study In Celiac Disease
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Brief: First Tracks Biotherapeutics - selling stockholders may sell up to 10.5 shares of common stock - SEC Filing
U.S. RESEARCH ROUNDUP- Alphabet, Colgate-Palmolive, Welltower
NASDAQ RESUMED AT 12:50 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:20 PM
NASDAQ RESUMED AT 10:27 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:21 AM